✦ LIBER ✦

Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study

✍ Scribed by Maarten LJ Smits; Johannes FW Nijsen; Maurice AAJ van den Bosch; Marnix GEH Lam; Maarten AD Vente; Willem PTM Mali; Alfred D van het Schip; Bernard A Zonnenberg

Book ID: 119608972
Publisher: The Lancet
Year: 2012
Tongue: English
Weight: 484 KB
Volume: 13
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(12)70334-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dabrafenib in patients with melanoma, un

Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial

✍ Gerald S Falchook; Georgina V Long; Razelle Kurzrock; Kevin B Kim; Tobias H Arke 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 576 KB

41 POSTER DCE-MRI endpoints reveal decre

41 POSTER DCE-MRI endpoints reveal decreased tumor vascularity in patients with liver metastases: a Phase I dose escalating study with IMC-1121B

✍ N.J. Serkova; J. Spratlin; S.G. Eckhardt; B. Milestone; E.G. Chiorean; H. Yousso 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 56 KB

166 A phase I dose-escalation study of a

166 A phase I dose-escalation study of anti-a5β1 integrin monoclonal antibody (M200) in patients with refractory solid tumors

✍ A. Ricart; G. Liu; A. Tolcher; G. Schwartz; J. Harris; R. Stagg; E. Rowinsky; G. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 297 KB

Phase I rapid dose-escalation study of A

Phase I rapid dose-escalation study of AGS-1C4D4, a human anti-PSCA (prostate stem cell antigen) monoclonal antibody, in patients with castration-resistant prostate cancer: a PCCTC trial

✍ Emmanuel S. Antonarakis; Michael A. Carducci; Mario A. Eisenberger; Samuel R. De 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 316 KB